Syapse Expands Into Asia With Korean Hospital Deal

Jan 31, 2018

|

CHICAGO (GenomeWeb) – Syapse, a maker of software to support precision oncology care, has entered the Asian market through a partnership with Seoul National University Hospital. A parallel deal with cloud IT company Megazone will allow the company to reach other potential customers in South Korea, Japan, and Vietnam.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Whirlwind Genetic Genealogy Year

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Getting Through the Backlog

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

Settlement After DNA Testing Questions

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

This Week in Nature

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.

Featured White Papers

BlueBee Data Security & Compliance

Whole Genome Sequencing of Microbial Communities for Scaling Microbiome and Metagenomic Studies

NGS is Accelerating Therapeutic Antibody Discovery - What Lies Beyond?

Powerful Bioinformatic Support for Specialized Therapeutic Antibody Discovery

May

07

Featured Webinar

Implementing a Multisite Clinical System for Genomics with Best-in-Class Tools: the GenoVic Project

This webinar will discuss the implementation of an enterprise-wide clinical genomics platform that is shared across 10 hospitals and research organizations in the Australian State of Victoria.

Jun

17

Featured Webinar

Personal and Clinical Utility of Polygenic Risk Scores: A Review of the Evidence

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Menu